Skip navigation

Otsuka Holdings Co. Ltd.

Pharmaceuticals
Japan
2016 Revenue (US$ Millions)$10,222
Revenue Growth (%)-16.24%
Net Income (US$ Millions)$791
Earnings Per Share (US$)$1.46
EPS Growth Rate (%)-9.27%
Profit Margin7.74%
Total Equity (US$ Millions)$14,625
Return on Equity (%)5.45%
Long Term Debt (US$ Millions)$1,658
Debt To Equity Ratio (%)0.11%
Total Assets (US$ Millions)$21,189
Current Assets (US$ Millions)$9,523
Current Liabilities (US$ Millions)$3,733
Cost of Goods Sold (US$ Millions)$3,474
Inventory TurnoverNA